Back to Search
Start Over
Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts
- Source :
- Cardiovascular research. 47(2)
- Publication Year :
- 2000
-
Abstract
- Objective: Although interest in diastolic heart failure is growing because of its clinical frequency, little is known about this type of heart failure. Our laboratory recently developed a diastolic heart failure model using Dahl salt-sensitive rat. In this model, gene expression of angiotensin-converting enzyme and endothelin (ET) system in the left ventricle was enhanced at heart failure stage without downregulation of angiotensin type 1a receptor mRNA level. However, the roles of these humoral systems in the transition to diastolic failure remain unclear. Methods: Subdepressor doses of angiotensin II type 1 (AT1) receptor and ET type A (ETA) receptor antagonists were administered in this model just after onset of hypertension, and their effects were investigated. Results: Neither AT1 nor ETA receptor blockade inhibited the early (13 weeks) compensatory left ventricular (LV) hypertrophy. This form of compensatory hypertrophy is associated with subnormal LV end-systolic stress, which was normalized by AT1 receptor blockade but not by ETA receptor blockade. Progression of LV hypertrophy and fibrosis and transition to heart failure (19 weeks) in the untreated rats were prevented by both antagonists, resulting in normalization of LV end-diastolic pressure and lung weight. AT1 receptor blockade, but not ETA receptor blockade, normalized time constant of LV relaxation. Enhanced gene expression for ET system in the left ventricle observed in the untreated rats was suppressed with AT1 receptor antagonist administration. ETA receptor blockade slightly but significantly elevated the AT1a receptor mRNA level as compared with the untreated rats. Conclusions: RAS and ET system contribute to the transition to diastolic heart failure through the development of excessive hypertrophy and ventricular fibrosis in hypertensive heart diseases, however, neither RAS nor ET system is mandatory for normal compensation for pressure overload. RAS apparently causes such diastolic effects at least partly through the ET system.
- Subjects :
- Endothelin Receptor Antagonists
Male
medicine.medical_specialty
Physiology
Heart Ventricles
Tetrazoles
Endothelin-Converting Enzymes
Peptidyl-Dipeptidase A
Left ventricular hypertrophy
Receptor, Angiotensin, Type 2
Receptor, Angiotensin, Type 1
Angiotensin Receptor Antagonists
Diastole
Physiology (medical)
Internal medicine
medicine
Animals
Aspartic Acid Endopeptidases
RNA, Messenger
Protein Precursors
Pressure overload
Heart Failure
Sulfonamides
Angiotensin II receptor type 1
Rats, Inbred Dahl
Receptors, Angiotensin
Dose-Response Relationship, Drug
Endothelin-1
business.industry
Receptors, Endothelin
Endothelins
Biphenyl Compounds
Diastolic heart failure
Metalloendopeptidases
medicine.disease
Receptor, Endothelin A
Angiotensin II
Rats
Endocrinology
Pyrimidines
Heart failure
Hypertension
Cardiology
Benzimidazoles
Cardiology and Cardiovascular Medicine
business
Endothelin receptor
Subjects
Details
- ISSN :
- 00086363
- Volume :
- 47
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Cardiovascular research
- Accession number :
- edsair.doi.dedup.....3f2891db9910ff8a346b983f2a4ff363